01 55GLAXO GRP LTD
02 55GLAXOSMITHKLINE
01 311116721*PED
02 147439393
03 67439393*PED
04 37488827
05 37498440
06 68161968
07 48183257
08 38309572
09 68534281
10 68746242
11 69333310
12 39750726
13 211090294
14 611116721
15 68161968*PED
16 98511304
17 68511304*PED
18 68534281*PED
19 68746242*PED
20 69333310*PED
01 20Y
02 90Blank
01 62Y
02 48Blank
01 62025-04-27
02 142025-05-21
03 42025-07-27
04 62025-11-21
05 92027-06-14
06 62027-10-02
07 62027-12-14
08 32027-12-18
09 62028-02-05
10 62028-04-02
11 62028-08-05
12 62029-02-26
13 32029-08-26
14 62030-03-08
15 62030-09-08
16 62030-10-11
17 52030-11-29
18 62031-04-11
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2099
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1424
Delist Requested :
Patent Use Description : LONG-TERM, ONCE DAILY ...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2025-04-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2100
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2100
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-07-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8183257
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-07-27
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1401
Delist Requested :
Patent Use Description : INDICATED FOR LONG-TER...
Patent Expiration Date : 2029-02-26
LOOKING FOR A SUPPLIER?
